Literature DB >> 31168829

A topical heparinoid-containing product improves epidermal permeability barrier homeostasis in mice.

Ye Yao1, Pan Guo1, Xiaoyue Feng1, Chunping Shen2,3, Junkai Huang1, Jiechen Zhang3,4, Peter M Elias3, Lizhi Hu1, Mao-Qiang Man3.   

Abstract

Because of the importance of epidermal functions, including stratum corneum hydration and maintenance of permeability barrier homeostasis, in the pathogenesis of a variety of cutaneous and systemic disorders, a wide range of products has been developed to improve epidermal functions. However, the underlying mechanisms whereby certain products, including heparinoid-containing product, are far little understood. In the present study, we assessed the impact of a heparinoid-containing product, Hirudoid® cream, on epidermal permeability barrier function and expression levels of a panel of epidermal mRNA related to the formation/maintenance of the permeability barrier in mouse skin. Our results showed that while the baseline levels of transepidermal water rates remained unchanged, treatment with Hirudoid® cream twice daily for 7 days significantly accelerated permeability barrier recovery and increased stratum corneum hydration. In parallel, expression levels of epidermal mRNA for certain differentiation marker-related proteins, lipid synthetic enzymes, keratinocyte proliferation and antimicrobial peptides also increased significantly. Together, these results provide the underlying mechanisms by which topical Hirudoid® cream improves epidermal permeability barrier and antimicrobial function. Because of its benefits for epidermal functions, heparinoid-containing product could be more useful in the management of skin conditions, characterized by abnormal permeability barrier and antimicrobial function.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  barrier function; differentiation; heparinoid; stratum corneum hydration

Year:  2019        PMID: 31168829      PMCID: PMC6663615          DOI: 10.1111/exd.13985

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  41 in total

Review 1.  Epidermal pathogenesis of inflammatory dermatoses.

Authors:  P M Elias; L C Wood; K R Feingold
Journal:  Am J Contact Dermat       Date:  1999-09

Review 2.  Coordinate regulation of epidermal differentiation and barrier homeostasis.

Authors:  P M Elias; K R Feingold
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  2001

Review 3.  Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group.

Authors:  H P Adams; R F Woolson; J Biller; W Clarke
Journal:  Haemostasis       Date:  1992

4.  Oral lichen planus: clinical and histological evaluation in an open trial using a low molecular weight heparinoid (sulodexide).

Authors:  Felice Femiano; Crispian Scully
Journal:  Int J Dermatol       Date:  2006-08       Impact factor: 2.736

Review 5.  Human beta-defensin-2.

Authors:  J M Schröder; J Harder
Journal:  Int J Biochem Cell Biol       Date:  1999-06       Impact factor: 5.085

6.  Comparative study of the efficacy of various moisturizers on the skin of the ASR miniature swine.

Authors:  K I O'Goshi; N Tabata; Y Sato; H Tagami
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  2000 Mar-Apr

7.  Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.

Authors:  Sophie Joly; Connie Maze; Paul B McCray; Janet M Guthmiller
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 8.  Overview of low molecular weight heparins and heparinoids: basic and clinical aspects.

Authors:  J Hirsh
Journal:  Aust N Z J Med       Date:  1992-10

9.  Oral erosive/ulcerative lichen planus: preliminary findings in an open trial of sulodexide compared with cyclosporine (ciclosporin) therapy.

Authors:  Felice Femiano; Fernando Gombos; Crispian Scully
Journal:  Int J Dermatol       Date:  2003-04       Impact factor: 2.736

10.  Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis.

Authors:  Lilly Y W Bourguignon; Mohamed Ramez; Eli Gilad; Patrick A Singleton; Mao-Qiang Man; Debra A Crumrine; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

View more
  4 in total

1.  Preventive effect of a heparinoid-containing product on the application site reaction of the rotigotine transdermal patch in Parkinson's disease: A pilot randomized clinical trial (the SkinHeRo study).

Authors:  Jinsoo Koh; Maiko Takahashi; Mayumi Sakata; Masaaki Yasui; Shoko Yorozu; Hidefumi Ito
Journal:  Clin Park Relat Disord       Date:  2021-08-13

2.  Efficacy and Safety of Mucopolysaccharide Polysulfate Cream for Non-Exudative Eczema: A Systematic Review and Meta-Analysis.

Authors:  Ming Li; Yan Li; Lujing Xiang; Linfeng Li
Journal:  Front Med (Lausanne)       Date:  2021-12-24

3.  Topical N-palmitoyl serinol, a commensal bacterial metabolite, prevents the development of epidermal permeability barrier dysfunction in a murine model of atopic dermatitis-like skin.

Authors:  Si Wen; Li Ye; Dan Liu; Bin Yang; Mao-Qiang Man
Journal:  Can J Vet Res       Date:  2021-07       Impact factor: 1.310

4.  Mutations in 3β-hydroxysteroid-δ8, δ7-isomerase paradoxically benefit epidermal permeability barrier homeostasis in mice.

Authors:  Erle Dang; George Man; Dale Lee; Debbie A Crumrine; Theodora M Mauro; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2020-11-30       Impact factor: 3.960

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.